Considering the #stockmarket trends this week, volatility is clearly not going anywhere anytime soon. Whether you’re trading penny stocks or higher-priced shares of companies, broad market events have impacted most sectors. But with a bit more optimism lately, some are looking for cues that the bear market is over and opportunities to buy the dip. With so much heavy selling, there are also much higher levels of short interest right now. It isn’t just #pennystocks experiencing big bets against them. Look at companies like GoHealth Inc (NASDAQ:GOCO). You might recall the company was mentioned earlier this month as one of the penny stocks under $1 to watch. Since the article was published, GoHealth completed a reverse split of its shares and now trades at a much higher price. That hasn’t pushed the pause button on short interest. Currently, according to sources like TDAmeritrade and Fintel.io, the short float percentage on GOCO stock sits well above 80%. This is also a stock priced at...
Trading #pennystocks has the potential to be a very profitable technique. However, due to the volatility, these trades are seen as having a more significant risk than other types of investments. For individuals seeking to build their portfolio with a higher risk in mind and possibly greater rewards, penny #stocks are a likely choice. You can choose what trends to watch for. There’s plenty to look for, whether it’s #shortsqueeze stocks, #insidertrading activity, unusual options, or positive momentum. Usually, the most crucial step is choosing penny stocks to add to your list based on your unique #trading style. One benefit of using analyst information is using the research they will conduct. Right now, they aren’t just concentrating on price fluctuation. They are looking for fundamental catalysts based on their current operations. #WallStreet firms have continued to support some of these names despite the low prices. What transpires over the coming weeks may determine how inves...
Best Penny Stocks For Your July 2021 List? 8 Biotechs To Watch Now One of the great things about biotech penny stocks is the potential of these companies. There are very few places that offer this kind of early access to potentially life-saving treatments. If you take a look at last year’s pandemic, some of the most unassuming names flourished. That was thanks to the fast-acting business acumen from some of these companies. One of the biggest highlights, at least among penny stock traders, was Novavax (NASDAQ: NVAX). Not only do companies have the potential to achieve what Novavax was able to under the right circumstances, but the industry is also full of big mergers and acquisitions. Early-stage companies develop clinical trial pipelines. Larger companies may then target these smaller firms as buyout candidates. For instance, Merck (NYSE: MRK) bought cancer drug research company VelosBio Inc. from Pappas Capital and other investors for $2.75 billion. Gilead Sciences (NASDAQ: GILD) pi...
Comments
Post a Comment